Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05315700
Title Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ORIC Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | GBR | CAN | AUS


No variant requirements are available.